Immune monitoring in cancer immunotherapy.

Slični predmeti

• High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
  od: Pittet, M, i dr.
  Izdano: (1999)
• An antigen-targeted approach to adoptive transfer therapy of cancer.
  od: Valmori, D, i dr.
  Izdano: (1999)
• CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
  od: Speiser, D, i dr.
  Izdano: (1999)
• Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
  od: Valmori, D, i dr.
  Izdano: (2000)
• Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
  od: Valmori, D, i dr.
  Izdano: (1999)